See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $27.1B | 1.7x | 7.2x | |
| $18.2B | 16.1x | 49.9x | |
| $17.2B | 11.2x | 33.5x | |
| $10.5B | 3.3x | 8.1x | |
| $7.5B | 9.9x | 36.6x | |
| $6.9B | 4.5x | 22.6x | |
| $4.5B | 13.0x | 30.7x | |
| $3.7B | 1.7x | 10.3x | |
| $3.1B | 2.2x | 8.2x | |
| $3.0B | 1.4x | 9.7x | |
| $2.8B | n/a | n/a | |
| $2.2B | 7.3x | 14.2x | |
| $1.7B | n/a | n/a | |
| $1.4B | 2.4x | 12.5x | |
| $1.3B | 6.0x | 22.9x | |
| $1.2B | 8.3x | 28.7x | |
| $1.1B | 1.0x | 4.0x | |
| $1.0B | 6.7x | 21.4x | |
| $1.0B | n/a | n/a | |
| $972M | n/a | n/a | |
| $945M | n/a | n/a | |
| $918M | 3.7x | 9.6x | |
| $731M | 6.2x | 52.2x | |
| $666M | 15.8x | 45.1x | |
| $660M | 1.5x | 7.2x | |
| $528M | 3.6x | 13.3x | |
| $499M | n/a | n/a | |
| $204M | 3.1x | n/a | |
| $179M | 2.3x | 12.5x | |
| $89.7M | n/a | n/a | |
| $51.9M | 1.3x | 4.8x | |
| $31.4M | n/a | n/a | |
| $22.5M | n/a | n/a | |
| $20.7M | 0.8x | -45.7x | |
| $16.7M | 11.6x | -1.6x | |
| $7.9M | n/a | n/a | |
| $5.5M | n/a | n/a | |
| $5.2M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| -$3.2M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals